NDC Package 25021-791-20 Lacosamide

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

25021-791-20

Package Description:

10 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS

Product Code:

25021-791

Proprietary Name:

Lacosamide

Non-Proprietary Name:

Lacosamide

Substance Name:

Lacosamide

Usage Information:

Lacosamide is used to prevent and control seizures. It is an anticonvulsant or antiepileptic drug. It works by reducing the spread of seizure activity in the brain.

11-Digit NDC Billing Format:

25021079120

Billing Unit:

ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

NDC to RxNorm Crosswalk:

RxCUI: 809974 - lacosamide 200 MG in 20 ML Injection

RxCUI: 809974 - 20 ML lacosamide 10 MG/ML Injection

RxCUI: 809974 - lacosamide 200 MG per 20 ML Injection

Product Type:

Human Prescription Drug

Labeler Name:

Sagent Pharmaceuticals

Dosage Form:

Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.

Administration Route(s):

Intravenous - Administration within or into a vein or veins.

Active Ingredient(s):

LACOSAMIDE 10 mg/mL

Pharmacologic Class(es):

Decreased Central Nervous System Disorganized Electrical Activity - [PE] (Physiologic Effect)

DEA Schedule:

Schedule V (CV) Substances

Sample Package:

FDA Application Number:

ANDA214301

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

03-17-2022

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

25021 - Sagent Pharmaceuticals
- 25021-791 - Lacosamide
  - 25021-791-20 - 10 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 25021-791-20?

The NDC Packaged Code 25021-791-20 is assigned to a package of 10 vial, glass in 1 carton / 20 ml in 1 vial, glass of Lacosamide, a human prescription drug labeled by Sagent Pharmaceuticals. The product's dosage form is injection, solution and is administered via intravenous form.

Is NDC 25021-791 included in the NDC Directory?

Yes, Lacosamide with product code 25021-791 is active and included in the NDC Directory. The product was first marketed by Sagent Pharmaceuticals on March 17, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 25021-791-20?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 25021-791-20?

The 11-digit format is 25021079120. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	25021-791-20	5-4-2	25021-0791-20

Table of Contents